Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Personalized Medicine Biomarkers Market Outlook 2026-2034: Applications Beyond Cancer Into Diseases Like Neurodegeneration and Cardiometabolic Conditions Presents New Opportunities

globenewswire.com
ABT Listed as a prominent company in the personalized medicine biomarkers market, suggesting participation in a growing sector without specific sentiment. TMO Identified as a key market player in the personalized medicine biomarkers sector, indicating its presence in a growing industry but without explicit sentiment. ILMN Named as a prominent company in the personalized medicine biomarkers market, suggesting its role in a growing field but without specific positive or negative indicators.

Personalized Medicine Biomarkers Market Outlook 2026-2034: Applications Beyond Cancer Into Diseases Like Neurodegeneration and Cardiometabolic Conditions Presents New Opportunities Dublin, March 04, 2026 (GLOBE NEWSWIRE) -- The "Personalized Medicine Biomarkers Market Outlook 2026-2034: Market Share, and Growth Analysis" has been added to ResearchAndMarkets.com's offering.

The Personalized Medicine Biomarkers Market is forecasted to grow from USD 21.52 billion in 2025 to USD 58.25 billion by 2034, reflecting a CAGR of 11.7%. This market forms the backbone of precision healthcare, bridging molecular insights to therapeutic decisions, clinical trials, and disease monitoring. The predominant applications include oncology, with expansion into neurology, cardiometabolic, and autoimmune disease management.

Driven by advancements such as next-generation sequencing and AI-driven analytics, the market sees demand from biopharma for risk mitigation, providers for clinical decision-making, and payers for cost-effective treatments. Competition is diverse, spanning diagnostic majors, precision-oncology labs, and bioinformatics firms, favoring players that offer a fully integrated portfolio.

Key Insights:

Regional Analysis:

Market Segmentation:

Key Market Players:

Prominent companies include Roche Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, and Illumina among others.

Market Analytics:

The evaluation involves tools like Porter's Five Forces, value chain mapping, and scenario-based modeling to understand supply-demand dynamics. The report assesses cross-sector influences, trade analytics, macroeconomic indicators, and recent technological innovations.

Competitive Intelligence:

Your Key Takeaways:

Key Attributes:

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/vn0riz

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment